Comparison Chart Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 150.85 USD | -5.20% |
|
-15.07% | -24.38% |
| 05-13 | Charles River Laboratories, Medipost Sign MoU on GMP-Compliant Testing | MT |
| 05-13 | Charles River Laboratories and Medipost sign non-exclusive MoU to advance GMP testing solutions | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Other Biotechnology & Medical Research | -5.20% | -15.07% | -24.38% | +7.01% | -53.26% | 7.27B |  | |  |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition